MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
about
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like StimulantsNovel psychoactive substances: the pharmacology of stimulants and hallucinogens.The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocolEffects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals."Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodentsUnderstanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45.An investigation of the stability of emerging new psychoactive substances.Synthetic Aminoindanes: A Summary of Existing Knowledge.Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites.In Vitro Neurochemical Assessment of Methylphenidate and Its "Legal High" Analogs 3,4-CTMP and Ethylphenidate in Rat Nucleus Accumbens and Bed Nucleus of the Stria Terminalis.
P2860
Q26752739-131E8690-1F7D-45B7-92A2-133893344DB4Q30251771-3C77D78F-B8AE-42B6-B7FD-7BB08F690F66Q36200336-535473F8-31C3-4E4B-B562-59FE700B31A8Q37663461-4EA23A07-7367-41F1-B177-39B3E5506069Q38246079-05B7731C-2CFA-4752-89AC-20DF93962369Q38382285-169396B2-FA20-4006-8809-8917A2AF17BBQ42395888-F77F5F11-CD91-4BD8-BBC9-2C1DB85D116BQ44061215-8B493EDB-EBD9-425E-8EC2-74B513168A87Q44276254-B53C1BBD-CF27-4F98-8238-91E1626B51C0Q47567624-B2151178-3590-4637-810D-269D973814C3Q47984706-63A9CFB6-B8BE-4CB8-A64B-EF37AA37FAA0Q55265475-EF1A2D39-F9FF-4F31-A74B-AB2940CDF08B
P2860
MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MDAI (5,6-methylenedioxy-2-ami ...... : a brief overview and update.
@en
type
label
MDAI (5,6-methylenedioxy-2-ami ...... : a brief overview and update.
@en
prefLabel
MDAI (5,6-methylenedioxy-2-ami ...... : a brief overview and update.
@en
P2093
P2860
P356
P1476
MDAI (5,6-methylenedioxy-2-ami ...... : a brief overview and update.
@en
P2093
A Hamid Ghodse
Fabrizio Schifano
Ornella Corazza
Simon Elliott
P2860
P304
P356
10.1002/HUP.2298
P50
P577
2013-07-01T00:00:00Z